Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$63.15 - $72.88 $94.2 Million - $109 Million
1,491,000 New
1,491,000 $102 Million
Q3 2022

Nov 14, 2022

SELL
$59.54 - $68.01 $899,054 - $1.03 Million
-15,100 Reduced 0.97%
1,537,539 $94.9 Million
Q2 2022

Aug 15, 2022

BUY
$57.72 - $65.01 $45.4 Million - $51.2 Million
787,150 Added 102.83%
1,552,639 $96 Million
Q1 2022

May 16, 2022

BUY
$57.92 - $72.58 $44.3 Million - $55.6 Million
765,489 New
765,489 $45.5 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Deerfield Management Company, L.P. (Series C) Portfolio

Follow Deerfield Management Company, L.P. (Series C) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.